Wogonin inhibits osteoclast formation induced by lipopolysaccharide

Phytotherapy Research

Volumn 24, Issue 7, 2010, Pages 964-968

  Jang, Sungil ^a,b   Bak, Eun Jung ^a   Kim, Minyoung ^a,b   Kim, Jin Moon ^a,b   Chung, Won Yoon ^a,b   Cha, Jeong Heon ^a,b   Yoo, Yun Jung ^a,b  

^a Yonsei University College of Dentistry   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Lipopolysaccharide; Osteoclastogenesis; Wogonin

Indexed keywords

CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E2; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PERIODONTITIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUGS, CHINESE HERBAL; FLAVANONES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NITROBENZENES; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SULFONAMIDES;

EID: 77954526792     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3013     Document Type: Article

References (22)

1. Boyce BF, Xing L. 2007. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9 Suppl 1: S1.
2. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
3. Chen YC, Shen SC, Chen LG, Lee TJ, Yang LL. 2001. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 61: 1417-1427.
4. Chi YS, Cheon BS, Kim HP. 2001. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol 61: 1195-1203.
5. Chi YS, Kim HP. 2005. Suppression of cyclooxygenase-2 expression of skin fibroblasts by wogonin, a plant flavone from Scutellaria radix. Prostaglandins Leukot Essent Fatty Acids 72: 59-66.
6. Choi HG, Kim JM, Kim BJ, Yoo YJ, Cha JH. 2007. Mouse strain-dependent osteoclastogenesis in response to lipopolysaccharide. J Microbiol 45: 566-571.
7. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. 2000. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12. (Pubitemid 30026926)
8. 3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones. Calcif Tissue Int 55: 114-119.
9. Jeffcoat MK. 1993. Bone loss in the oral cavity. J Bone Miner Res 8 Suppl 2: S467-S473.
10. 2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells. Prostaglandins Leukot Essent Fatty Acids 77: 181-186.
11. 2 signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/ receptor activator of nuclear factor-κB (RANK) ligand/RANK system. Endocrinology 146: 1991-1998.
12. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. 1996. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 64: 2371-2380. (Pubitemid 26226792)
13. Rogers JE, Li F, Coatney DD, Otremba J, Kriegl JM, Protter TA, Higgins LS, Medicherla S, Kirkwood KL. 2007a. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol 78: 1992-1998.
14. Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, Giannobile WV, Kirkwood KL. 2007b. Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol 78: 550-558.
15. Sakuma Y, Tanaka K, Suda M, Komatsu Y, Yasoda A, Miura M, Ozasa A, Narumiya S, Sugimoto Y, Ichikawa A, Ushikubi F, Nakao K. 2000. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. Infect Immun 68: 6819-6825. (Pubitemid 32463389)
16. Socransky SS, Haffajee AD. 2005. Periodontal microbial ecology. Periodontol 2000 38: 135-187.
17. 2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172: 2504-2510.
18. 3 in osteoclast differentiation and function. Methods Enzymol 282: 223-235.
19. Tai MC, Tsang SY, Chang LY, Xue H. 2005. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev 11: 141-150. (Pubitemid 41278978)
20. Takahashi N, Udagawa N, Suda T. 1999. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 256: 449-455. (Pubitemid 29301126)
21. 2 production in macrophages. Eur J Pharmacol 406: 477-481.
22. Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J. 2004. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-κB activity. J Bone Miner Res 19: 1905-1916.